Aim
To compare the transcutaneous oxygen pressure results observed in patients with severe walking limitation during standard procedures (3.2 km/hr, 10% slope) versus during a test performed at a low speed (2 km/hr, 10% slope).
Methods
In 31 patients, the decrease from rest of oxygen pressure (DROP) index was measured on both buttocks, both thighs and both calves during two consecutive tests on treadmill. The maximal walking time (MWT) and the minimal DROP values (DROPmin) observed during the 2 tests were compared with t test. Correlation of DROPmin values during the slow and standard procedure was performed with linear regression. The −15 mmHg cut‐off value defined for standard test interpretation was used arbitrarily for the interpretation of slow test results.
Results
MWT was 80 ± 52 s versus 376 ± 269 s at standard and slow speed, respectively (p < .001). No difference on all recorded DROPmin values at a standard (−9.5 ± 6.9 mmHg) and slow (−10.5 ± 7.9 mmHg) speed was found; n = 186, p = .168. Coefficient of correlation between DROPmins found at the two tests was r = 0.820 (p < .01), with regression line close to the line of identity. With the identical −15 mmHg cut‐off, 166 (89.2%) of 186 the results were classified similarly after standard and slow procedures.
Conclusion
Specific slow treadmill procedures are not mandatory in patients with extremely short test durations when performing standard (3.2 km/hr 10% slope) exercise oximetry. In patients expected to be unable to walk at standard speed, the −15 mmHg normal limit seems to be valid for the interpretation of tests with a slow procedure (2.0 km/hr).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.